Epic Research & Diagnostics Inc — Form D/A
Epic Research & Diagnostics Inc of Scottsdale, AZ, a company, filed a Form D amendment with the SEC on 2009-08-13. The offering totals $2.0M, of which $1.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-08-13
- Form: D/A
- Accession: 0001414511-09-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $1.9M
- Remaining: $85K
- Minimum investment: $10K
- Investors: 20
- Date of first sale: 2008-12-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-109522
Issuer
- Name: Epic Research & Diagnostics Inc
- CIK: 0001414511
- Entity type: Corporation
- Jurisdiction: AZ
- Incorporated: 2006
- Address: 9811 East Bell Road Suite 105, Scottsdale, AZ, 85260
- Phone: 480-477-5242
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Michael C Hammer | Director | Scottsdale, AZ |
| Diana Hunt | Director | Scottsdale, AZ |
| A Nicholas Rizzo | Director | Scottsdale, AZ |
| Nancy R Rizzo | Director | Scottsdale, AZ |
| Kenneth R Waters | Director | Scottsdale, AZ |
| Nancy R Rizzo | Executive Officer | Scottsdale, AZ |
| Mary Ellen Mittelstaedt | Director | Scottsdale, AZ |
| Mary Ellen Mittelstaedt | Executive Officer | Scottsdale, AZ |
Other filings by this issuer (1)
More